Nosological classification (ICD-10)
- J30 Vasomotor and allergic rhinitis
- J31 Chronic rhinitis, nasopharyngitis and pharyngitis
- J32 Chronic sinusitis
- J35 Chronic diseases of the tonsils and adenoids
- Y96 Work related factors
- Y97 Factors associated with environmental pollution
- Z100* CLASS XXII Surgical practice
- Z29.8 Other specified preventive measures
- Z54.0 Convalescent period after surgery
- Z57 Occupational exposure to hazards
- Z58 Problems related to physical environmental factors
Composition and release form
| Nasal drops | 1 ml |
| sea salt (calculated on dry matter) | 10.8 mg |
| incl. sodium | not <2.5 mg |
| magnesium | not <350 mcg |
| calcium | not <8 mcg |
| potassium | not <100 mcg |
| hydrocarbonates | not <30 mcg |
| excipients: water for injection |
in dropper bottles made of polymer material, 5 or 10 ml; in a cardboard pack there is 1 dropper bottle.
| Nasal spray | 1 ml |
| sea salt (calculated on dry matter) | 10.8 mg |
| incl. sodium | not <2.5 mg |
| magnesium | not <350 mcg |
| calcium | not <8 mcg |
| potassium | not <100 mcg |
| hydrocarbonates | not <30 mcg |
| excipients: water for injection |
in polymer bottles with a spray nozzle of 20 or 50 ml; 1 bottle in a cardboard pack.
Pharmacodynamics
Morenasal® is an isotonic, sterile solution of natural sea salt in water for injection, administered as nasal drops or nasal spray, containing natural minerals and trace elements.
Morenazal® helps maintain the normal physiological state of the nasal mucosa, thins mucus and normalizes its formation in goblet cells of the mucous membrane. Removes allergens and pathogens, excess mucus, crusts, dust, tiny particles that clog the nasal passages and make breathing difficult.
The microelements included in the drug have an anti-inflammatory effect, stimulate recovery processes, improve the function of the ciliated epithelium, which increases the resistance of the nasal mucosa to pathogenic bacteria and viruses, and promotes its cleansing.
For rhinitis of any etiology (including allergic and vasomotor), the drug helps to wash away and remove allergens and haptens from the nasal mucosa, as well as reduce the local inflammatory process.
Reduces secretions, relieves swelling of the nasal mucosa and restores free breathing, reduces the risk of otitis media, and shortens the period of respiratory diseases.
Morenasal® helps remove scales and crusts from the nasal passages after surgery without the risk of bleeding.
The isotonicity of Morenazal® avoids sinus pain that may occur when instilling hypertonic nasal solutions. Increases the effectiveness of the use of local drugs.
Used for hygienic purposes, the drug helps cleanse the nasal mucosa from street and indoor dust that has settled on it.
Does not contain preservatives.
Pharmacological properties
Rinomaris is a drug for intranasal use.
Xylometazoline has an alpha-adrenomimetic effect: it causes a constriction of the blood vessels of the nasal mucosa, thus eliminating swelling and hyperemia of the nasopharyngeal mucosa. Facilitates nasal breathing during rhinitis. In therapeutic concentrations it does not irritate the mucous membranes and does not cause hyperemia. The effect occurs a few minutes after application and lasts for 12 hours.
Sterilized sea water, which is part of the drug Rinomaris, helps maintain the normal physiological state of the nasal mucosa, thins mucus and normalizes its production in the goblet cells of the nasal mucosa.
Trace elements improve the function of the ciliated epithelium, which reduces adverse local reactions such as irritation and/or dryness of the nasopharyngeal mucosa.
Indications for the drug Morenasal®
Nasal drops:
acute, allergic, vasomotor rhinitis;
chronic diseases of the nasal cavity, nasopharynx, paranasal sinuses, incl. accompanied by dryness of the nasal mucosa;
adenoids;
prevention of nasal cavity infections in the autumn-winter period, with changing climatic conditions (rooms with air conditioning and/or central heating), the presence of polluted atmospheric air (smokers, vehicle drivers, hot and dusty workshops);
preparation for the introduction of other drugs into the nasal cavity (to improve their absorption);
washing wounds of the nasal cavity and paranasal sinuses before and after surgical interventions;
hygiene procedures for the nasal cavity.
Nasal spray:
acute rhinitis in children and adults (as a symptomatic remedy);
acute and chronic inflammatory diseases of the nasal cavity, sinuses and nasopharynx;
infectious, allergic and atrophic rhinitis, rhinosinusitis, rhinopharyngitis;
prevention of inflammation of the paranasal sinuses (sinusitis, frontal sinusitis, sinusitis);
preparation for the introduction of other drugs into the nasal cavity (to improve their absorption);
adenoids in children;
period after surgical interventions on the nasal cavity;
allergic and vasomotor rhinitis in adults and children (especially in persons with hypersensitivity to drugs or with a predisposition to it);
as a hygienic means for washing the nasal cavity;
prevention of nasal cavity infections in the autumn-winter period;
patients suffering from dry nasal mucosa, and persons living and working in rooms with air conditioning and/or central heating (in order to preserve the physiological characteristics of the mucous membrane in altered microclimatic conditions);
patients who constantly expose the mucous membrane of the upper respiratory tract to negative effects (by smoking, driving vehicles, working in hot and dusty workshops, as well as in harsh climatic conditions).
Morenasal 20ml spray
Morenasal 20ml spray
pharmachologic effect
Morenasale
Composition and release form Morenasal nasal drops:
1 ml contains sea salt (in terms of dry matter) 10.8 mg, incl. sodium non-excipients: water for injection;
in dropper bottles made of polymer material, 5 or 10 ml; in a cardboard pack there is 1 dropper bottle.
Morenasal spray for nasal use:
1 ml contains sea salt (in terms of dry matter) 10.8 mg, incl. sodium non-excipients: water for injection;
in polymer bottles with a spray nozzle of 20 or 50 ml; 1 bottle in a cardboard pack.
pharmachologic effect
Morenazal has an anti-inflammatory effect.
Indications Morenasal nasal drops:
acute, allergic, vasomotor rhinitis;
chronic diseases of the nasal cavity, nasopharynx, paranasal sinuses, incl. accompanied by dryness of the nasal mucosa;
adenoids;
prevention of nasal cavity infections in the autumn-winter period, with changing climatic conditions (rooms with air conditioning and/or central heating), the presence of polluted atmospheric air (smokers, vehicle drivers, hot and dusty workshops);
preparation for the introduction of other drugs into the nasal cavity (to improve their absorption);
washing wounds of the nasal cavity and paranasal sinuses before and after surgical interventions;
hygiene procedures for the nasal cavity. Morenasal nasal spray:
acute rhinitis in children and adults (as a symptomatic remedy);
acute and chronic inflammatory diseases of the nasal cavity, sinuses and nasopharynx;
infectious, allergic and atrophic rhinitis, rhinosinusitis, rhinopharyngitis;
prevention of inflammation of the paranasal sinuses (sinusitis, frontal sinusitis, sinusitis);
preparation for the introduction of other drugs into the nasal cavity (to improve their absorption);
adenoids in children;
period after surgical interventions on the nasal cavity;
allergic and vasomotor rhinitis in adults and children (especially in persons with hypersensitivity to drugs or with a predisposition to it);
as a hygienic means for washing the nasal cavity;
prevention of nasal cavity infections in the autumn-winter period;
patients suffering from dry nasal mucosa, and persons living and working in rooms with air conditioning and/or central heating (in order to preserve the physiological characteristics of the mucous membrane in altered microclimatic conditions);
patients who constantly expose the mucous membrane of the upper respiratory tract to negative effects (by smoking, driving vehicles, working in hot and dusty workshops, as well as in harsh climatic conditions).
Contraindications
hypersensitivity to the components of Morenazal;
children under 1 year of age (for nasal spray).
Use during pregnancy and breastfeeding
The drug can be used during pregnancy and breastfeeding according to indications.
Side effects
Allergic reactions are possible.
Directions for use and doses
Intranasally (into the nasal passages).
When using Morenasal nasal drops For therapeutic purposes
Children from the 1st day of life to 1 year - 1-2 drops in each nasal passage 1-3 times a day.
Children aged 1 to 7 years - 2 drops in each nasal passage 4 times a day. Children over 1 year of age can use Morenazal® nasal spray.
Children aged 7 to 16 years - 2 drops in each nasal passage 4-6 times a day.
Adults: 2-3 drops in each nasal passage 4-8 times a day.
The course of treatment is 2–4 weeks. It is recommended to repeat the course of treatment after 1 month. For hygienic purposes
In children from the 1st day of life to 1 year, it is recommended to clean the nasal mucosa to preserve its physiological characteristics in the form of instilling Morenasal drops, 1-2 drops into each nasal passage 2-3 times a day.
To soften and remove nasal secretions, drops are instilled into each nasal passage in the required amount, removing the remaining liquid flowing from the nose with a tissue or cotton wool. The procedure can be repeated many times until the secretions accumulated in the nasal passage are softened and removed. When using Morenasal nasal spray
In children aged 1 to 2 years: the child should be placed with his head turned to one side, then the drug should be injected into the nostril located above. Sit the child down and clear the nose. Repeat the procedure with the other nostril.
In adults and children over 2 years of age: tilt your head to the side and inject the drug into the nostril located above. After 2-3 minutes, blow your nose. Repeat the procedure with the other nostril.
Storage conditions
In a place protected from light, at a temperature not exceeding 25 °C.
Shelf life – 2 years.
Conditions for dispensing from pharmacies Dispensed with a doctor's prescription
Directions for use and doses
Intranasally (into the nasal passages).
When using Morenasal® nasal drops
For medicinal purposes
Children from the 1st day of life to 1 year - 1-2 drops in each nasal passage 1-3 times a day.
Children aged 1 to 7 years - 2 drops in each nasal passage 4 times a day. Children over 1 year of age can use Morenazal® nasal spray.
Children aged 7 to 16 years - 2 drops in each nasal passage 4-6 times a day.
Adults: 2-3 drops in each nasal passage 4-8 times a day.
The course of treatment is 2–4 weeks. It is recommended to repeat the course of treatment after 1 month.
For hygienic purposes
In children from the 1st day of life to 1 year, it is recommended to clean the nasal mucosa to preserve its physiological characteristics in the form of instilling Morenasal® drops, 1-2 drops into each nasal passage 2-3 times a day.
To soften and remove nasal secretions, drops are instilled into each nasal passage in the required amount, removing the remaining liquid flowing from the nose with a tissue or cotton wool. The procedure can be repeated many times until the secretions accumulated in the nasal passage are softened and removed.
When using Morenasal® nasal spray
In children aged 1 to 2 years: the child should be placed with his head turned to one side, then the drug should be injected into the nostril located above. Sit the child down and clear the nose. Repeat the procedure with the other nostril.
In adults and children over 2 years of age: tilt your head to the side and inject the drug into the nostril located above. After 2-3 minutes, blow your nose. Repeat the procedure with the other nostril.
Recommended single doses of the drug (number of injections in each nostril) and frequency of use per day are shown in the table.
| Patient age | Treatment | Hygiene |
| from 1 year to 2 years | 1 spray into each nostril 2–4 times a day | 1 injection into each nostril 1–2 times a day |
| from 2 years to 7 years | 2 sprays in each nostril 4 times a day | 1–2 sprays into each nostril 1–3 times a day |
| from 7 years to 16 years | 2 sprays in each nostril 4–6 times a day | 2 sprays into each nostril 2–4 times a day |
| Adults and teenagers over 16 years of age | 2–3 sprays into each nostril 4–8 times a day | 2–3 sprays into each nostril 3–6 times a day |
Morenasal
Intranasally.
Aqua Maris: for hygienic purposes - for infants using turundas moistened with the drug 2 times a day or by instilling 1-2 drops into each nasal passage 2-3 times a day, for children 1-7 years old - 1-2 injections in each nasal 1-3 times a day, children 7-16 years old - 2 injections 1-3 times a day, adults - 2-3 injections in each nasal passage 3-6 times a day.
Treatment of diseases of the mucous membrane of the nasal cavity, paranasal sinuses, nasopharynx: children under 1 year old - 2 drops in each nasal passage, children 1-7 years old, 1-2 injections in each nasal passage 1-3 times a day, children 7-16 years - 2 injections into each nasal passage 4-6 times a day, adults - 2-3 injections into each nasal passage 4-8 times a day. The course of treatment is 2-4 weeks, if necessary, the course of treatment is repeated after 1 month.
To soften and remove nasal discharge: the drug is injected or instilled repeatedly (removing excess liquid with cotton wool or a handkerchief) into each nasal passage until the discharge is completely softened and removed.
Physiomer: for hygienic purposes and for the prevention of diseases of the mucous membrane of the nasal cavity and nasopharynx in children under 2 years of age (nasal spray for children) - 1 injection daily into each nasal passage; for diseases of the nasal cavity and nasopharynx (including acute respiratory viral infections) - 2-4 injections daily into each nasal passage. Adults and children over 2 years of age (nasal spray): for hygiene of the nasal mucosa and disease prevention - 1 injection daily into each nasal passage; for diseases of the nasal cavity and nasopharynx (including acute respiratory viral infections) - 2-4 injections daily into each nasal passage. Adults and children over 6 years of age (nasal spray Forte): for diseases of the nasal cavity and nasopharynx (including acute respiratory viral infections) - 2-4 injections daily into each nasal passage; care for the nasal mucosa after surgery - daily 4-6 injections into each nasal passage. Duration of use - from 7 days to several months.
Fluimarin: adults and children over 2 years old are administered 1-2 doses of aerosol into each nasal passage 3-6 times a day. Children under 2 years old: 1 dose in each nasal passage 3-6 times a day.
Marimer: adults and children under 1 year, one dose of aerosol in each nasal passage for therapeutic purposes 4-6 times a day, for hygienic purposes 1-4 times a day. Nasal drops: adults and children over 1 year old, 2 drops in each nasal passage for therapeutic purposes 4-6 times a day, for hygienic purposes - 1-4 times a day.
